Clinical Trial Update: Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial to assess safety and efficacy of Tigan for preventing nausea and vomiting during initiation and treatment with Apokyn in Parkinson's dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Apokyn (apomorphine)
• TIGAN (TRIMETHOBENZAMIDE HYDROCHLORIDE)

Snippet

Sponsor: Ipsen | Conditions: Parkinson's Disease | Phase 4 | Status: COMPLETED | Results posted: 2013-05-20